Abbott faces more litigation over AIDS drug

(AP) -- When Abbott Laboratories Inc. hiked up the price of a popular AIDS drug by 400 percent in 2003, executives prepared for the inevitable public relations hit, but assured themselves the backlash would be brief. Nearly five years later, the accusations against Abbott are still flying.

Read the whole article on Physorg

More from Physorg